Application 209713
- Type
- ANDA
- Sponsor
- LUPIN ATLANTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209713-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209713-001 | AB1 |
| A209713-001 | AB2 |
| A209713-001 | AB3 |
| A209713-002 | AB1 |
| A209713-002 | AB2 |
| A209713-002 | AB3 |
| A209713-003 | AB1 |
| A209713-003 | AB2 |
| A209713-003 | AB3 |
| A209713-004 | AB1 |
| A209713-004 | AB2 |
| A209713-004 | AB3 |
| A209713-005 | AB1 |
| A209713-005 | AB2 |
| A209713-005 | AB3 |
| A209713-006 | AB1 |
| A209713-006 | AB2 |
| A209713-006 | AB3 |
| A209713-007 | AB1 |
| A209713-007 | AB2 |
| A209713-007 | AB3 |
| A209713-008 | AB1 |
| A209713-008 | AB2 |
| A209713-008 | AB3 |
| A209713-009 | AB1 |
| A209713-009 | AB2 |
| A209713-009 | AB3 |
| A209713-010 | AB1 |
| A209713-010 | AB2 |
| A209713-010 | AB3 |
| A209713-011 | AB1 |
| A209713-011 | AB2 |
| A209713-011 | AB3 |
| A209713-012 | AB1 |
| A209713-012 | AB2 |
| A209713-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209713-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-001 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-001 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-002 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-002 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-003 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-003 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-004 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-004 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-005 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-005 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-006 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-006 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-007 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-007 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-008 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-008 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-009 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-009 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-010 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-010 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-010 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-011 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-011 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-011 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-012 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-012 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209713-012 | AB3 | 3 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209713-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209713-001 | AB2 | 2 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209713-001 | AB3 | 3 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209713-002 | AB1 | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4f26f9dc-cf49-4b55-a6f7-f2f579893ee4 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ffc34bc6-5de5-addb-e053-6294a90a25be | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 49136b34-1bc1-ec4e-e063-6394a90ac9dd | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e2291336-1188-48f4-af52-d12ac892f80f | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 98d7ce2b-a248-4ed0-a2ec-d28ba623531e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9cb3417-e8cb-13f8-e053-2a95a90a294b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ca4634a5-d8d7-48a4-e053-2995a90a0cd4 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 51655-528 51655-479 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | dac0af5d-622c-e18c-e053-2995a90a5739 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f317a597-4644-746a-e053-2995a90a807f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 51655-985 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 51655-989 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dfd5b8-06a5-2728-e053-2995a90a298e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 51655-923 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dff641-ced3-bae3-e053-2a95a90a2e29 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 51655-924 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e3667ab1-2bd9-4e0d-8a97-f907593e7954 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | eb120047-a43b-40a4-9f55-067b1b51edda | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fea284d8-0514-498b-a37c-405730b5f6a2 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | bcf10012-8920-4737-92f5-7401ee0c5894 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 884f9fa1-58aa-4ff7-934f-106a0470e747 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Major Pharmaceuticals | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 0904-6956 0904-6955 0904-6957 0904-6953 0904-6951 0904-6950 0904-6954 0904-6949 0904-6952 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0904-6949 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6949 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6950 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6950 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6951 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6951 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6952 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6952 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6953 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6953 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6954 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6954 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6955 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6955 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6956 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6956 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6957 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 0904-6957 | Levothyroxine Sodium | Levothyroxine Sodium | Major Pharmaceuticals | ANDA | Current |
| 50090-4947 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4947 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4951 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4951 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-5133 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-5792 | Levothyroxine Sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 51655-479 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals, LLC | ANDA | Current |
| 51655-528 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals, LLC | ANDA | Current |
| 51655-923 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals | ANDA | Current |
| 51655-924 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals | ANDA | Current |
| 51655-985 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals | ANDA | Current |
| 51655-989 | Levothyroxine Sodium | Levothyroxine Sodium | Northwind Pharmaceuticals | ANDA | Current |
| 55154-3558 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 55154-3559 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 55154-3560 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 55154-3561 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 55154-3562 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 55154-3563 | Levothyroxine Sodium | Levothyroxine Sodium | Cardinal Health | ANDA | Current |
| 60687-453 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-453 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-453 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-453 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-464 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-464 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-464 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-464 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-475 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-475 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-475 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-475 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-486 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-486 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-486 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-486 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-497 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-497 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-497 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-497 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-508 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-508 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-508 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-508 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-519 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-519 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-519 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-519 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-530 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-530 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-530 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-530 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-541 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-541 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-541 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-541 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-552 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-552 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-552 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-563 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-563 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 60687-563 | Levothyroxine Sodium | Levothyroxine Sodium | American Health Packaging | ANDA | Current |
| 68180-965 | Levothyroxine Sodium | Levothyroxine Sodium | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-965 | Levothyroxine Sodium | Levothyroxine Sodium | Lupin Pharmaceuticals, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71492 | SUPPL | 2022-06-30 |